This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Learn which commodities offer high returns to enhance your investment portfolio. Make informed decisions to grow your wealth.
26,939 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
The S&P 500 dropped around 1.5% as crude surged on geopolitical worries, reviving inflation fears and tempering expec...
As AI brings new pricing for memory, Micron stands at the crossroads of momentum and valuation. This guide breaks dow...
Morgan Stanley trims its U.S. growth outlook after energy costs erode the uplift from tax refunds. The revision highl...
A bold NYC budget claim sparks debate about deficits and government finance. Learn how the idea of a zero-based, bala...
As the AI arms race accelerates, Microsoft leans on Copilot to reverse signals of lost momentum. Early traction and p...
Bitcoin wobbled amid renewed volatility as traders weigh key support levels and the risk of capitulation, with analys...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
As Synopsys reports strong Q2 results, investors weigh AI-driven catalysts against a heavy debt load and amortization...
As Bitcoin sits in the current price range, analysts lay out a spectrum of 2030 outcomes. This story unpacking scenar...
Nvidia remains the marquee name in the 2026 AI stock rally, while AMD gains ground and Palantir stalls. Analysts sket...
Christopher Nolan delivers a blockbuster opening for The Odyssey, outperforming Oppenheimer and marking his best star...